BASi Opens new Facility in Europe to Better Serve Pharmaceutical and Biotech Companies
News Jun 18, 2009
BASi has opened a new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded laboratories provides clients with enhanced capabilities throughout Europe.
Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies.
BASi Europe also supplies the complete line of BASi instruments and equipment, including the Culex Automated In Vivo Sampling System, as well as providing support for customers and distributors throughout Europe.
“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe.
“We currently have multiple industry standard LC-MS/MS stations, as well as LC-EC and other analytical technologies, and we have invested in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE